Polar Asset Management Partners Inc. Jazz Pharmaceuticals PLC Transaction History

Polar Asset Management Partners Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $3.18 Million - $3.78 Million	-27,800 Reduced 88.25%	3,700 $455,000
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $610,000 - $726,550	-5,000 Reduced 13.7%	31,500 $4.08 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $22.7 Million - $27.2 Million	-185,100 Reduced 83.53%	36,500 $4.52 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $9.37 Million - $11.2 Million	69,900 Added 46.08%	221,600 $32.4 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $1.8 Million - $2.22 Million	-13,900 Reduced 8.39%	151,700 $24.2 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $443,065 - $564,130	3,500 Added 2.16%	165,600 $22.1 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $368,134 - $438,516	2,600 Added 1.63%	162,100 $25.3 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $7.25 Million - $8.98 Million	55,900 Added 53.96%	159,500 $24.8 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $7.9 Million - $9.6 Million	65,900 Added 174.8%	103,600 $13.2 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $4.85 Million - $6.97 Million	37,700 New	37,700 $4.91 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.